Synlogic (SYBX) Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. MH

Go back to Synlogic (SYBX) Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria
(NASDAQ: SYBX) Delayed: 0.56 --0 (-0%)
Previous Close $0.56    52 Week High $ 
Open $0.56    52 Week Low $ 
Day High $0.56    P/E N/A 
Day Low $0.56    EPS $ 
Volume 301